These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39169706)

  • 1. TFE3-rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape.
    Agaimy A; Acosta AM; Cheng L; Collins K; Fridman E; Schubart C; Williamson SR; Hartmann A; Trpkov K
    Histopathology; 2024 Nov; 85(5):783-793. PubMed ID: 39169706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
    Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
    Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
    Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
    Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEComa with ASPSCR1::TFE3 fusion: expanding the molecular genetic spectrum of TFE3-rearranged PEComa with an emphasis on overlap with alveolar soft part sarcoma.
    Zhao M; Huang Y; Yin X; Xu J; Sun Y; Wang J
    Histopathology; 2024 Feb; 84(3):482-491. PubMed ID: 37936565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFE3 -Rearranged PEComa/PEComa-like Neoplasms : Report of 25 New Cases Expanding the Clinicopathologic Spectrum and Highlighting its Association With Prior Exposure to Chemotherapy.
    Argani P; Gross JM; Baraban E; Rooper LM; Chen S; Lin MT; Gocke C; Agaimy A; Lotan T; Suurmeijer AJH; Antonescu CR
    Am J Surg Pathol; 2024 Jul; 48(7):777-789. PubMed ID: 38597260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
    Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [TFE3-rearranged perivascular epithelioid cell tumors: a clinicopathological analysis of eight cases].
    Qin Y; Yang L; Zhang HJ; Wei J; Liu YX; Zhang WH; Wen Z; Wang Z; Fan LN
    Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):822-829. PubMed ID: 39103264
    [No Abstract]   [Full Text] [Related]  

  • 8. PEComa-like Neoplasms Characterized by ASPSCR1-TFE3 Fusion: Another Face of TFE3-related Mesenchymal Neoplasia.
    Argani P; Wobker SE; Gross JM; Matoso A; Fletcher CDM; Antonescu CR
    Am J Surg Pathol; 2022 Aug; 46(8):1153-1159. PubMed ID: 35848761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
    Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
    Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features.
    Shen Q; Rao Q; Xia QY; Yu B; Shi QL; Zhang RS; Zhou XJ
    Virchows Arch; 2014 Nov; 465(5):607-13. PubMed ID: 25239799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A distinctive subset of PEComas harbors TFE3 gene fusions.
    Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.
    Argani P; Aulmann S; Karanjawala Z; Fraser RB; Ladanyi M; Rodriguez MM
    Am J Surg Pathol; 2009 Apr; 33(4):609-19. PubMed ID: 19065101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular PEComas are frequently melanotic and TFE3-translocated: report of two cases including the first description of PRCC-TFE3 fusion in PEComa.
    Gao Y; Chen G; Chow C; Io I; Wong EWN; Tsui WMS; Lam WY; To KF; Chan JKC; Cheuk W
    Virchows Arch; 2021 May; 478(5):1025-1031. PubMed ID: 32676967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar Soft Part Sarcoma of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases With Emphasis on its Distinction From Morphologic Mimics.
    Schoolmeester JK; Carlson J; Keeney GL; Fritchie KJ; Oliva E; Young RH; Nucci MR
    Am J Surg Pathol; 2017 May; 41(5):622-632. PubMed ID: 28009610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous PEComa does not harbour TFE3 gene fusions: immunohistochemical and molecular study of 17 cases.
    Llamas-Velasco M; Mentzel T; Requena L; Palmedo G; Kasten R; Kutzner H
    Histopathology; 2013 Jul; 63(1):122-9. PubMed ID: 23711163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
    Green WM; Yonescu R; Morsberger L; Morris K; Netto GJ; Epstein JI; Illei PB; Allaf M; Ladanyi M; Griffin CA; Argani P
    Am J Surg Pathol; 2013 Aug; 37(8):1150-63. PubMed ID: 23715164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal epithelioid angiomyolipomas overexpress TFE3 and the TFE3-regulated gene TRIM63 in the absence of TFE3 rearrangement.
    Collins K; Bridge JA; Mehra R; Mannan R; Dickson BC; Lotan TL; Idrees MT; Ulbright TM; Acosta AM
    Virchows Arch; 2024 Sep; 485(3):471-478. PubMed ID: 38971946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors.
    Maloney N; Giannikou K; Lefferts J; Bridge JA; Linos K
    Hum Pathol; 2018 Dec; 82():125-130. PubMed ID: 29626599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.
    Hodge JC; Pearce KE; Wang X; Wiktor AE; Oliveira AM; Greipp PT
    Mod Pathol; 2014 Jan; 27(1):113-27. PubMed ID: 23828314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations.
    Wang XT; Xia QY; Ye SB; Wang X; Li R; Fang R; Shi SS; Zhang RS; Tan X; Chen JY; Sun K; Teng XD; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Mod Pathol; 2018 Sep; 31(9):1346-1360. PubMed ID: 29713041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.